U.S. Liposomal Bupivacaine Market Trends 2034: Advancements in Regional Anesthesia and Postoperative Pain Control
  The United States represents the largest contributor to the North American Liposomal Bupivacaine Market, supported by a high volume of surgical interventions, growing awareness of multimodal pain management strategies, and increasing focus on reducing opioid dependence. The country's healthcare system has witnessed significant adoption of long-acting local anesthetics in orthopedic,...
0 Kommentare 0 Geteilt 20 Ansichten 0 Bewertungen